Deenan Pillay
Deenan Pillay
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei africacentre.ac.za
Titel
Zitiert von
Zitiert von
Jahr
2011 update of the drug resistance mutations in HIV-1
VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, R Shafer, ...
Topics in antiviral medicine 19 (4), 156, 2011
12002011
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ...
PloS one 4 (3), e4724, 2009
9702009
2017 update of the drug resistance mutations in HIV-1
AM Wensing, V Calvez, HF Günthard, VA Johnson, R Paredes, D Pillay, ...
Topics in antiviral medicine 24 (4), 132, 2016
6852016
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel
MS Hirsch, HF Günthard, JM Schapiro, FB Vézinet, B Clotet, SM Hammer, ...
Clinical Infectious Diseases 47 (2), 266-285, 2008
6102008
Update of the Drug Resistance Mutations in HIV-1: 2005
VA Johnson, F Brun-Vézinet, B Clotet, B Conway, D Pillay, J Schapiro, ...
Top. HIV Med 14 (3), 125-130, 2006
4942006
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
BG Gazzard, J Anderson, A Babiker, M Boffito, G Brook, G Brough, ...
HIV medicine 9 (8), 563-608, 2008
4602008
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global …
RK Gupta, MR Jordan, BJ Sultan, A Hill, DHJ Davis, J Gregson, ...
The Lancet 380 (9849), 1250-1258, 2012
3982012
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …
L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ...
The Lancet infectious diseases 11 (5), 363-371, 2011
3972011
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
RW Shafer, SY Rhee, D Pillay, V Miller, P Sandstrom, JM Schapiro, ...
AIDS (London, England) 21 (2), 215, 2007
3852007
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration
R Kantor, DA Katzenstein, B Efron, AP Carvalho, B Wynhoven, P Cane, ...
PLoS Med 2 (4), e112, 2005
3672005
Update of the drug resistance mutations in HIV-1: March 2013
VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, RW Shafer, ...
Topics in antiviral medicine 21 (1), 6, 2013
3092013
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and …
RK Gupta, A Hill, AW Sawyer, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima, ...
The Lancet infectious diseases 9 (7), 409-417, 2009
2962009
Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups
S Hué, D Pillay, JP Clewley, OG Pybus
Proceedings of the National Academy of Sciences 102 (12), 4425-4429, 2005
2682005
HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy
S Hué, JP Clewley, PA Cane, D Pillay
Aids 18 (5), 719-728, 2004
2432004
Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials
R Gupta, A Hill, AW Sawyer, D Pillay
Clinical infectious diseases 47 (5), 712-722, 2008
2402008
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study
A Banerjee, L Pasea, S Harris, A Gonzalez-Izquierdo, A Torralbo, ...
The Lancet 395 (10238), 1715-1725, 2020
2392020
An open-label study of tenofovir in HIV-1 and hepatitis B virus co-infected individuals
M Nelson, S Portsmouth, J Stebbing, M Atkins, A Barr, G Matthews, ...
Aids 17 (1), F7-F10, 2003
2292003
Update of the drug resistance mutations in HIV-1: 2007
VA Johnson, F Brun-Vézinet, B Clotet, HF Gunthard, DR Kuritzkes, ...
Top HIV Med 15 (4), 119-125, 2007
2262007
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression …
RK Gupta, J Gregson, N Parkin, H Haile-Selassie, A Tanuri, LA Forero, ...
The Lancet infectious diseases 18 (3), 346-355, 2018
2182018
Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study
UK Group on Transmitted HIV Drug Resistance
Bmj 331 (7529), 1368, 2005
2162005
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20